Literature DB >> 2686039

The role of single photon emission computed tomography in bone scintigraphy.

I P Murray1, J Dixon.   

Abstract

The increasing availability for routine nuclear medicine studies of single photon emission computed tomography (SPECT) reflects the realisation of its ability to improve lesional detection and the assessment of location. This is achieved by removing unwanted surrounding radioactivity and thus delineating with greater clarity deeper areas of preferential accumulation. By removing the super-imposition of structures, SPECT offers considerable potential for improved diagnostic accuracy in suspected bone and joint disease. Time and cost, however, necessitate a selective use of the technique. The maximum advantages arise from studies of the head, spine, skull and knees. The role of SPECT does, in some instances, lie in providing increased sensitivity in the detection of focal uptake while in others it complements alternative imaging modalities by identifying the functional status of an abnormality and thus may demonstrate its clinical significance. Since such information may be obtained by planar scintigraphy using techniques such as pinhole collimation, continuing evaluation is essential to ascertain the precise indications for SPECT imaging.

Entities:  

Mesh:

Year:  1989        PMID: 2686039     DOI: 10.1007/bf00351747

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  29 in total

1.  Significance of solitary spine abnormalities on technetium-99m bone imaging.

Authors:  P Thivolle; L Mathieu; P Mathieu; M Raynal; S E Bouyoucef; J Damideaux; E Vignon; M Berger
Journal:  Clin Nucl Med       Date:  1988-07       Impact factor: 7.794

2.  Normal anatomy of the lumbosacral spine and pelvis. A correlation of SPECT and radiographic techniques.

Authors:  G F Gates
Journal:  Clin Nucl Med       Date:  1988-05       Impact factor: 7.794

3.  Diagnosis of discitis by SPECT technetium-99m MDP scintigram. A case report.

Authors:  D Swanson; I Blecker; H Gahbauer; V J Caride
Journal:  Clin Nucl Med       Date:  1987-03       Impact factor: 7.794

4.  Value of gallium-67 SPECT in a patient with "malignant" otitis externa.

Authors:  K Behjati; C M Boyd; S Balachandran; C Pallin
Journal:  Clin Nucl Med       Date:  1987-03       Impact factor: 7.794

5.  The application of single photon emission computed tomography to the diagnosis of ankylosing spondylitis of the spine.

Authors:  H Jacobsson; S A Larsson; L Vestersköld; N Lindvall
Journal:  Br J Radiol       Date:  1984-02       Impact factor: 3.039

6.  Tc-99m medronate scintigraphy in mandibular condylar hyperplasia.

Authors:  I P Murray; J C Ford
Journal:  Clin Nucl Med       Date:  1982-10       Impact factor: 7.794

7.  Evaluation of meniscus tears of the knee by radionuclide imaging.

Authors:  J V Marymont; M A Lynch; C E Henning
Journal:  Am J Sports Med       Date:  1983 Nov-Dec       Impact factor: 6.202

8.  Computerized skeletal scintigraphy for assessment of mandibular asymmetry.

Authors:  G J Cisneros; L B Kaban
Journal:  J Oral Maxillofac Surg       Date:  1984-08       Impact factor: 1.895

9.  Changing indications for bone scintigraphy in patients with osteosarcoma.

Authors:  H Goldstein; B J McNeil; E Zufall; N Jaffe; S Treves
Journal:  Radiology       Date:  1980-04       Impact factor: 11.105

10.  Usefulness of SPECT in evaluating osteosarcoma metastases to the lung.

Authors:  G A Kirk; E E Schulz
Journal:  Clin Nucl Med       Date:  1987-05       Impact factor: 7.794

View more
  2 in total

1.  The diagnostic value of triple head single photon emission computed tomography (3H-SPECT) in avascular necrosis of the femoral head.

Authors:  K Y Kim; S H Lee; D H Moon; H Y Nah
Journal:  Int Orthop       Date:  1993       Impact factor: 3.075

Review 2.  Clinical spectrum and diagnostic pitfalls of multiple abnormal uptakes on bone scintigraphy.

Authors:  Fumihiro Tsubaki; Seiji Kurata; Shuji Nagata; Kiminori Fujimoto; Toshi Abe
Journal:  Jpn J Radiol       Date:  2016-09-29       Impact factor: 2.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.